Literature DB >> 32187028

Preoperative Opioid Use and Readmissions Following Surgery.

Ruiqi Tang1, Katherine B Santosa2, Joceline V Vu3, Lewei A Lin4, Yen-Ling Lai5, Michael J Englesbe6, Chad M Brummett7, Jennifer F Waljee2.   

Abstract

OBJECTIVE: To assess the association between preoperative opioid exposure and readmissions following common surgery. SUMMARY BACKGROUND DATA: Preoperative opioid use is common, but its effect on opioid-related, pain-related, respiratory-related, and all-cause readmissions following surgery is unknown.
METHODS: We analyzed claims data from a 20% national Medicare sample of patients ages ≥ 65 with Medicare Part D claims undergoing surgery between January 1, 2009 and November 30, 2016. We grouped patients by the dose, duration, recency, and continuity of preoperative opioid prescription fills. We used logistic regression to examine the association between prior opioid exposure and 30-day readmissions, adjusted for patient risk factors and procedure type.
RESULTS: Of 373,991 patients, 168,579 (45%) filled a preoperative opioid prescription within 12 months of surgery, ranging from minimal to chronic high use. Preoperative opioid exposure was associated with higher rate of opioid-related readmissions, compared with naive patients [low: aOR=1.63, 95% CI=1.26-2.12; high: aOR=3.70, 95% CI=2.71-5.04]. Preoperative opioid exposure was also associated with higher risk of pain-related readmissions [low: aOR=1.27, 95% CI=1.23-1.32; high: aOR=1.62, 95% CI=1.53-1.71] and respiratory-related readmissions [low: aOR=1.10, 95% CI=1.05-1.16; high: aOR=1.44, 95% CI=1.34-1.55]. Low, moderate, and high chronic preoperative opioid exposures were predictive of all-cause readmissions (low: OR 1.09, 95% CI: 1.06-1.12); high: OR 1.23, 95% CI: 1.18-1.29).
CONCLUSIONS: Higher levels of preoperative opioid exposure are associated with increased risk of readmissions after surgery. These findings emphasize the importance of screening patients for preoperative opioid exposure and creating risk mitigation strategies for patients.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 32187028      PMCID: PMC7935087          DOI: 10.1097/SLA.0000000000003827

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  40 in total

1.  Preoperative opioid use and postoperative pain associated with surgical readmissions.

Authors:  Elise A Dasinger; Laura A Graham; Tyler S Wahl; Joshua S Richman; Samantha J Baker; Mary T Hawn; Tina Hernandez-Boussard; Amy K Rosen; Hillary J Mull; Laurel A Copeland; Jeffrey C Whittle; Edith A Burns; Melanie S Morris
Journal:  Am J Surg       Date:  2019-02-28       Impact factor: 2.565

2.  Preoperative Opioid Use Is Associated with Higher Readmission and Revision Rates in Total Knee and Total Hip Arthroplasty.

Authors:  Jack Weick; Harpreet Bawa; Douglas R Dirschl; Hue H Luu
Journal:  J Bone Joint Surg Am       Date:  2018-07-18       Impact factor: 5.284

Review 3.  Opioid Use Disorders: Perioperative Management of a Special Population.

Authors:  Emine Nalan Ward; Aurora Naa-Afoley Quaye; Timothy E Wilens
Journal:  Anesth Analg       Date:  2018-08       Impact factor: 5.108

4.  Prediction of Complications, Readmission, and Revision Surgery Based on Duration of Preoperative Opioid Use: Analysis of Major Joint Replacement and Lumbar Fusion.

Authors:  Nikhil Jain; John L Brock; Azeem Tariq Malik; Frank M Phillips; Safdar N Khan
Journal:  J Bone Joint Surg Am       Date:  2019-03-06       Impact factor: 5.284

5.  Preoperative Opiate Use Independently Predicts Narcotic Consumption and Complications After Total Joint Arthroplasty.

Authors:  Joshua C Rozell; Paul M Courtney; Jonathan R Dattilo; Chia H Wu; Gwo-Chin Lee
Journal:  J Arthroplasty       Date:  2017-04-12       Impact factor: 4.757

6.  The Fifth Vital Sign: Postoperative Pain Predicts 30-day Readmissions and Subsequent Emergency Department Visits.

Authors:  Tina Hernandez-Boussard; Laura A Graham; Karishma Desai; Tyler S Wahl; Elise Aucoin; Joshua S Richman; Melanie S Morris; Kamal M Itani; Gordon L Telford; Mary T Hawn
Journal:  Ann Surg       Date:  2017-09       Impact factor: 12.969

7.  Preoperative Opioid Misuse is Associated With Increased Morbidity and Mortality After Elective Orthopaedic Surgery.

Authors:  Mariano E Menendez; David Ring; Brian T Bateman
Journal:  Clin Orthop Relat Res       Date:  2015-02-19       Impact factor: 4.176

8.  Variation in surgical-readmission rates and quality of hospital care.

Authors:  Thomas C Tsai; Karen E Joynt; E John Orav; Atul A Gawande; Ashish K Jha
Journal:  N Engl J Med       Date:  2013-09-19       Impact factor: 91.245

9.  Prevalence of Preoperative Opioid Use and Characteristics Associated With Opioid Use Among Patients Presenting for Surgery.

Authors:  Paul E Hilliard; Jennifer Waljee; Stephanie Moser; Lynn Metz; Michael Mathis; Jenna Goesling; David Cron; Daniel J Clauw; Michael Englesbe; Goncalo Abecasis; Chad M Brummett
Journal:  JAMA Surg       Date:  2018-10-01       Impact factor: 14.766

10.  Classifying Preoperative Opioid Use for Surgical Care.

Authors:  Joceline V Vu; David C Cron; Jay S Lee; Vidhya Gunaseelan; Pooja Lagisetty; Matthew Wixson; Michael J Englesbe; Chad M Brummett; Jennifer F Waljee
Journal:  Ann Surg       Date:  2020-06       Impact factor: 13.787

View more
  2 in total

1.  Ultrasound-Guided Femoral Nerve Block in Geriatric Patients with Hip Fracture in the Emergency Department.

Authors:  Tou-Yuan Tsai; Kar Mun Cheong; Yung-Cheng Su; Ming-Chieh Shih; Su Weng Chau; Mei-Wen Chen; Chien-Ting Chen; Yi-Kung Lee; Jen-Tang Sun; Kuan-Fu Chen; Kuo-Chih Chen; Eric H Chou
Journal:  J Clin Med       Date:  2022-05-14       Impact factor: 4.964

2.  Risk-reducing mastectomy: a case series of 124 procedures in Brazilian patients.

Authors:  Antônio Luiz Frasson; Martina Lichtenfels; Alessandra Anton Borba de Souza; Betina Vollbrecht; Ana Beatriz Falcone; Mônica Adriana Rodriguez Martinez Frasson; Fernanda Barbosa
Journal:  Breast Cancer Res Treat       Date:  2020-03-25       Impact factor: 4.872

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.